73 related articles for article (PubMed ID: 23877848)
1. HS N-sulfation and iduronic acids play an important role in the infection of respiratory syncytial virus in vitro.
Dong LQ; Wang XQ; Guo YN; Wu J; Li S; Yu P; Wang Z
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1864-8. PubMed ID: 23877848
[TBL] [Abstract][Full Text] [Related]
2. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
Hallak LK; Collins PL; Knudson W; Peeples ME
Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
[TBL] [Abstract][Full Text] [Related]
3. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection.
Guo Y; Wang Z; Dong L; Wu J; Zhai S; Liu D
Nephrology (Carlton); 2008 Oct; 13(7):545-53. PubMed ID: 19161362
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.
Hallak LK; Spillmann D; Collins PL; Peeples ME
J Virol; 2000 Nov; 74(22):10508-13. PubMed ID: 11044095
[TBL] [Abstract][Full Text] [Related]
5. Target selection of heparan sulfate hexuronic acid 2-O-sulfotransferase.
Smeds E; Feta A; Kusche-Gullberg M
Glycobiology; 2010 Oct; 20(10):1274-82. PubMed ID: 20554947
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
Teng MN; Whitehead SS; Collins PL
Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
[TBL] [Abstract][Full Text] [Related]
7. [Toll-like receptor 4 expression and function of respiratory syncytial virus-infected airway epithelial cells].
Xie XH; Liu EM; Yang XQ; Law HK; Li X; Wang LJ; Liu W; Xu WF
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Mar; 31(3):213-7. PubMed ID: 18785522
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus.
Techaarpornkul S; Collins PL; Peeples ME
Virology; 2002 Mar; 294(2):296-304. PubMed ID: 12009871
[TBL] [Abstract][Full Text] [Related]
9. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.
Li W; Shen HH
Chin Med J (Engl); 2007 Jan; 120(1):5-11. PubMed ID: 17254480
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression.
Tsutsumi H; Takeuchi R; Ohsaki M; Seki K; Chiba S
J Leukoc Biol; 1999 Jul; 66(1):99-104. PubMed ID: 10410996
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection and the tight junctions of nasal epithelial cells.
Tsutsumi H; Kojima T; Hirakawa S; Masaki T; Okabayashi T; Yokota S; Fujii N; Himi T; Sawada N
Adv Otorhinolaryngol; 2011; 72():153-6. PubMed ID: 21865717
[TBL] [Abstract][Full Text] [Related]
12. Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model.
Hament JM; Aerts PC; Fleer A; van Dijk H; Harmsen T; Kimpen JL; Wolfs TF
Pediatr Res; 2005 Dec; 58(6):1198-203. PubMed ID: 16306193
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha.
Garofalo R; Mei F; Espejo R; Ye G; Haeberle H; Baron S; Ogra PL; Reyes VE
J Immunol; 1996 Sep; 157(6):2506-13. PubMed ID: 8805651
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells.
Behera AK; Kumar M; Matsuse H; Lockey RF; Mohapatra SS
Biochem Biophys Res Commun; 1998 Oct; 251(3):704-9. PubMed ID: 9790973
[TBL] [Abstract][Full Text] [Related]
15. Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.
Crim RL; Audet SA; Feldman SA; Mostowski HS; Beeler JA
J Virol; 2007 Jan; 81(1):261-71. PubMed ID: 17050595
[TBL] [Abstract][Full Text] [Related]
16. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
[TBL] [Abstract][Full Text] [Related]
17. Two novel fusion inhibitors of human respiratory syncytial virus.
Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection.
O'donnell DR; Milligan L; Stark JM
Virology; 1999 Apr; 257(1):198-207. PubMed ID: 10208933
[TBL] [Abstract][Full Text] [Related]
19. Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity.
Schuurhof A; Bont L; Hodemaekers HM; de Klerk A; de Groot H; Hofland RW; van de Pol AC; Kimpen JL; Janssen R
Eur Respir J; 2012 Jun; 39(6):1475-81. PubMed ID: 22267765
[TBL] [Abstract][Full Text] [Related]
20. [Effects of respiratory syncytial virus upon expressions of mRNA and protein of intercellular adhesion molecule-1 in human embryonic lung fibroblast cells].
Chen CX; Wang SC; Hu Y; Xu JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2420-3. PubMed ID: 20137698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
